Alteration of Intestinal Microflora Is Associated With Reduction in Abdominal Bloating and Pain in Patients With Irritable Bowel Syndrome
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The influence of the gastrointestinal (GI) microflora in patients with irritable bowel syndrome (IBS) has not been clearly elucidated. This study was undertaken to see if patients with IBS have an imbalance in their normal colonic flora, as some bacterial taxa are more prone to gas production than others. We also wanted to study whether the flora could be altered by exogenous supplementation. In a previous study we have characterized the mucosa-associated lactobacilli in healthy individuals and found some strains with good colonizing ability. Upon colonization, they seemed to reduce gas formation. METHODS: The study comprised 60 patients with IBS and a normal colonoscopy or barium enema. Patients fulfilling the Rome criteria, without a history of malabsorption, and with normal blood tests underwent a sigmoidoscopy with biopsy. They were randomized into two groups, one receiving 400 ml per day of a rose-hip drink containing 5 × 107 cfu/ml of Lactobacillus plantarum (DSM 9843) and 0.009 g/ml oat flour, and the other group receiving a plain rose-hip drink, comparable in color, texture, and taste. The administration lasted for 4 wk. The patients recorded their own GI function, starting 2 wk before the study and continuing throughout the study period. Twelve months after the end of the study all patients were asked to complete the same questionnaire regarding their symptomatology as at the start of the study. RESULTS: All patients tolerated the products well. The patients receiving Lb. plantarum had these bacteria on rectal biopsies. There were no major changes of Enterobacteriaceae in either group, before or after the study, but the Enterococci increased in the placebo group and remained unchanged in the test group. Flatulence was rapidly and significantly reduced in the test group compared with the placebo group (number of days with abundant gas production, test group 6.5 before, 3.1 after vs 7.4 before and 5.6 after for the placebo group). Abdominal pain was reduced in both groups. At the 12-month follow-up, patients in the test group maintained a better overall GI function than control patients. There was no difference between the groups regarding bloating. Fifty-nine percent of the test group patients had a continuous intake of fermented products, whereas the corresponding figure for the control patients was 73%. CONCLUSIONS: The results of the study indicate that the administration of Lb. plantarum with known probiotic properties decreased pain and flatulence in patients with IBS. The fiber content of the test solution was minimal and it is unlikely that the fiber content could have had any effect. This type of probiotic therapy warrants further studies in IBS patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some probiotic strains, either single (Bifidobacterium Infantis 36524, Lactobacillus Plantarum 299v) or combined (VSL#3), have been associated with a significant alleviation of IBS symptoms, [14][15][16][17] while others proved ineffective.[18][19][20]”
In the citing paper
“Lactobacillus (L.) plantarum 299v reduced flatulence and abdominal pain in patients with IBS [7].”
From A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial (2010) · cites this paper as [7]
In the citing paper
“Few randomized-controlled trials on IBS and probiotics have investigated possible modifications of microbiota, and knowledge on the role of microbiota modulation in symptom relief is therefore limited. 6, 34”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [6]
Citations
Cites
Bergey's Manual of Systematic Bacteriology
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-5-448_7 · Cited by 2,925
Epidemiology of colonic symptoms and the irritable bowel syndrome
Talley, N. J., Zinsmeister, A. R., van Dyke, C., & Melton, L. J. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90717-y · Cited by 648
Abnormal colonic fermentation in irritable bowel syndrome
King, T., Elia, M., & Hunter, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02146-1 · Cited by 473
The normal Lactobacillus flora of healthy human rectal and oral mucosa
Ahrné, Nobaek, Jeppsson, Adlerberth, Wold, & Molin (1998) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1998.00480.x · Cited by 439
Johansson, M. L., Molin, G., Jeppsson, B., Nobaek, S., Ahrné, S., & Bengmark, S. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.1.15-20.1993 · Cited by 426
Self-citationControlled treatment trials in the irritable bowel syndrome: A critique
Klein, K. B. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90319-8 · Cited by 383
The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach
Drossman, D. A., & Thompson, W. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-1009 · Cited by 309
Irritable bowel syndrome in office-based practice in the United States
Everhart, J. E., & Renault, P. F. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90275-p · Cited by 306
CONTROLLED STUDY OF PSYCHOTHERAPY IN IRRITABLE BOWEL SYNDROME
Svedlund, J., Ottosson, J.-O., Sjödin, I., & Dotevall, G. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90678-5 · Cited by 275
Colonic Myoelectric Activity in the Irritable Bowel Syndrome
Snape, W. J., Carlson, G. M., & Cohen, S. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80141-2 · Cited by 260
Molin, G., Jeppsson, B., Johansson, M. ‐., Ahrné, S., Nobaek, S., Ståhl, M., & Bengmark, S. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb03031.x · Cited by 188
Self-citationJohansson, M.-L., Nobaek, S., Berggren, A., Nyman, M., Björck, I., Ahrné, S., Jeppsson, B., & Molin, G. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(98)00055-5 · Cited by 187
Self-citationRandomly amplified polymorphic DNA (RAPD) for rapid typing of Lactobacillus plantarum strains
Johansson, M.-L., Quednau, M., Molin, G., & Ahrné, S. (1995) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.1995.tb01030.x · Cited by 158
Self-citationTreatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk.
Ritchie, J. A., & Truelove, S. C. (1979) · BMJ · doi:10.1136/bmj.1.6160.376 · Cited by 154
Maxwell, P., Mendall, M., & Kumar, D. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05276-8 · Cited by 133
Irritable bowel syndrome: pathogenesis and management
Thompson, W. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)90705-l · Cited by 81 · cited 1×
“, food intake, endocrine imbalance, disturbances in the intestinal bacterial flora, malabsorption, postoperative changes, and psychosomatic influences (3, 4).”
BackgroundJOHANSSON, M.-L., Quednau, M., Ahrné, S., et al. (1995) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-45-4-670 · Cited by 57
Self-citationWyatt, G. M., Bayliss, C. E., Lakey, A. F., Bradley, H. K., Hunter, J. O., & Jones, V. A. (1988) · Journal of Medical Microbiology · doi:10.1099/00222615-26-4-295 · Cited by 34 · cited 1×
“no major differences in the fecal flora, compared with controls, were seen”
BackgroundLancaster-Smith, M., & Chapman, C. (1985) · Gastroenterology · doi:10.1007/978-94-011-7781-8_13 · Cited by 26
Research works printed but not linked: 6
- Keaton K.W., 1985, Irritable bowel syndrome, 203
- Balsari A., 1982, Microbiology, 5, 185
- Brenner D.J., 1937, Bergey's manual of systematic bacteriology, 1, 408
- Orskov F., 1919, Bergey's manual of systematic bacteriology, 1, 420
- Drossman D.A., 1990, Gastroenterology, 3, 159
- Chadda V.S., 1983, J Assoc Physicians India, 31, 425
Cited by
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Probiotics and their fermented food products are beneficial for health
Parvez, S., Malik, K. A., Ah Kang, S., & Kim, H.-Y. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02963.x · Cited by 1,435
Hemarajata, P., & Versalovic, J. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12459294 · Cited by 1,083
“A clinical study demonstrated decreased pain and flatulence in patients with IBS that received a 4-week treatment with a rose-hip drink containing 5 × 107 colony-forming units (CFU)/ml of L. plantarum DSM 9843 per day [Nobaek et al. 2000].”
BackgroundPostinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Metadata
- Authors
- Nobaek, S., Johansson, M.-L., Molin, G., Ahrné, S., & Jeppsson, B.
- Affiliations
- Lund University (SE)
- Probi (SE)
- Corresponding author
- Jeppsson, Bengt
- Venue
- American Journal of Gastroenterology
- Published
- 2000-05
- Volume
- 95
- Issue
- 5
- Pages
- 1231-1238
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W4248627171
- Cited by
- 653
- References
- 19
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 24 · 2022: 13 · 2021: 27 · 2020: 18 · 2019: 15 · 2018: 19 · 2017: 23 · 2016: 15 · 2015: 20 · 2014: 35 · 2013: 24 · 2012: 37
- FWCI
- 25.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- irritable bowel syndrome, gut microbiota, Lactobacillus plantarum, probiotic supplementation, flatulence, abdominal pain, bloating, Enterococcus, Enterobacteriaceae, fermented foods, dysbiosis, long-term follow-up
- MeSH terms
- Adult, Aged, Bacteria, Colonic Diseases, Functional, Double-Blind Method, Feces, Female, Flatulence, Humans, Intestinal Mucosa, Intestines, Lactobacillus, Male, Middle Aged, Abdominal Pain, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.